Neuromod Devices Ltd. develops and commercializes neuromodulation technologies, including an FDA-approved device for treating tinnitus.

Endovascular Engineering, Inc. develops the Hēlo Thrombectomy System, a novel technology for removing clots in venous thromboembolism (VTE).

Alesi Surgical develops technology to manage surgical smoke using electrical filtration, improving health and workflow in operating theatres.

CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.

Nouscom is a clinical-stage immuno-oncology company specializing in off-the-shelf and personalized cancer immunotherapies using a proprietary viral vector platform.